NIH-funded research R01 grant

Understanding Skin Barrier Differences

Official title: Skin Barrier Adaptation

Funded at Henry Ford Health System · NIH-11128592 · Data updated 2026-11-12

This project explores how our skin's protective barrier and vitamin D production adapt to different environments, especially looking at differences between people of European and African descent.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionHenry Ford Health System
NIH-funded
Lab location1 site (Detroit, United States)
Project startJuly 19, 2022
Project endJune 30, 2027
Funding year2025
Award (this year)$346,154
NIH project number5R01AR079888-04
Project IDNIH-11128592 on NIH RePORTER

Who could benefit from this research

Could help

This foundational research is relevant to anyone interested in skin health, especially individuals of European or African ancestry, as it explores genetic differences in skin function.

Less likely to help

Patients seeking immediate new treatments or direct clinical interventions will not directly benefit from this basic science project.

What this research studies

Our skin's outer layer, the epidermis, protects us from the environment and makes vitamin D. When this layer doesn't work well, it can lead to skin infections and inflammation. We've found that a specific gene, involucrin (IVL), which is important for skin function, shows different activity levels in people of European and African ancestry, suggesting our skin has adapted over time. This research aims to understand how IVL affects vitamin D receptor function in the skin, which is crucial for skin health and immune responses. By studying these mechanisms, we hope to learn more about how skin adapts and functions differently across populations.

Why it matters

Potential benefit: If successful, this work could lead to a better understanding of skin health disparities and new ways to address skin conditions, infections, and inflammation, particularly in diverse populations.

How similar studies have gone: This project builds on recent discoveries about human epidermal evolution and a newly identified role for involucrin in modulating vitamin D receptor signaling, representing an emerging paradigm.

Where this research is happening

  • Henry Ford Health System
    Detroit, United States
    Active

Researchers

  • Principal investigator: Strong, Cristina de Guzman — Henry Ford Health System
  • Study coordinator: Strong, Cristina de Guzman

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.